FindTrial
Sign In

COMPARISON THE POTENCY OF ROPIVACAINE AND LEVOBUPIVACAINE WHEN GIVEN AS SPINAL ANAESTHESIA IN LOWER ABDOMEN AND LOWER LIMB SURGERIES

Comparison of Intrathecal Ropivacaine versus Levobupivacaine in lower abdomen and lower limb surgeries

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/02/023473
Enrollment
90
Registered
2020-02-20
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissue

Interventions

Intervention1: GROUP R (Ropivacaine group) - Patients who will receive 0.75% ropivacaine intrathecally: Patients will receive 3 ml of 0.75% ropivacaine intrathecally Control Intervention1: GROUP L

Sponsors

Sri Venkateshwaraa Medical College Hospital And Research Centre Ariyur Puducherry INDIA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: PATIENTS WITH ASA1 AND ASA 2 UNDERGOING LOWER ABDOMEN AND LOWER LIMB SURGERIES

Exclusion criteria

Exclusion criteria: 1.PATIENTS WITH ANY CONTRAINDICATIONS FOR SPINAL ANESTHESIA- INFECTION AT INJECTION SITE, PATIENT REFUSAL, COAGULOPATHIES 2.PSYCHIATRIC ILLNESS 3.ALLERGIC TO LOCAL ANESTHETICS 4.PREGNANCY

Design outcomes

Primary

MeasureTime frame
ONSET AND DURATION OF SENSORY BLOCKADE ONSET AND DURATION OF MOTOR BLOCKADE DURATION OF ANALGESIATimepoint: Onset of blockade until 24 hours—

Secondary

MeasureTime frame
HAEMODYNAMIS CHANGES NAUSEA,VOMITING,PRURITIS,SHIVERINGTimepoint: Onset of blockade until 24 hours—

Countries

India

Contacts

Public ContactDr ArthiA

Sri Venkateshwaraa Medical College Hospital and Research center

drraghuram70@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026